S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

OSTX OS Therapies Incorporated

1.6101

-0.0299 (-1.82%)

01 Mar 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

OS Therapies (AMEX:OSTX)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more OS Therapies Charts.

OS Therapies (AMEX:OSTX)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more OS Therapies Charts.

OS Therapies Incorporated News

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 1 March 2025 (12 hours ago) • Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Saturday 1 March 2025 (12 hours ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Saturday 1 March 2025 (12 hours ago) • Edgar (US Regulatory)

Join OS Therapies’ Exclusive Live Investor Webinar and Q&A Session on February 27
Thursday 27 February 2025 (2 days ago) • Business Wire

OS Therapies Forms Subsidiary OS Drug Conjugates and Initiates Review of Strategic Options for its tunable ADC & Drug Conjugates Platforms
Monday 24 February 2025 (5 days ago) • Business Wire

OS Therapies Receives Patent Notice of Allowance from U.S. Patent & Trademark Office Covering Commercial Manufacturing of OST-HER2
Thursday 20 February 2025 (1 week ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 19 February 2025 (1 week ago) • Edgar (US Regulatory)

OS Therapies Initiates Commercial-ready Manufacturing of OST-HER2 to Support Anticipated Biologics Licensing Authorization (BLA) Filing
Friday 14 February 2025 (2 weeks ago) • Business Wire

Form PRE 14A - Other preliminary proxy statements
Saturday 8 February 2025 (3 weeks ago) • Edgar (US Regulatory)

OS Therapies Provides Corporate Update
Tuesday 4 February 2025 (4 weeks ago) • Business Wire

Form S-1 - General form for registration of securities under the Securities Act of 1933
Saturday 1 February 2025 (4 weeks ago) • Edgar (US Regulatory)

OS Therapies Agrees to Acquire All Listeria Monotygenes-based Immuno-Oncology Programs and IP Assets from Ayala Pharmaceuticals, Adding Phase 2 Lung Cancer and Phase 1 Prostate Cancer Programs to Pipeline
Thursday 30 January 2025 (1 month ago) • Business Wire

More OS Therapies Incorporated News Articles

Woodside Petroleum

Gold vs US Dollar

Newcrest Mining

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions